240
Participants
Start Date
August 4, 2021
Primary Completion Date
March 1, 2023
Study Completion Date
February 20, 2024
Gonadotrophin releasing hormone antagonist protocol
Women will receive antagonist (Cetrorelix 0.25mg) once subcutaneously daily from day 6 of ovarian stimulation till the day of the ovulation trigger or
Progestin-primed ovarian stimulation protocol
Women will receive oral medroxyprogesterone 10 mg daily or Duphaston 10mg bd from Day 3 till the day of ovulation trigger.
Shanghai first Maternity and Infant health hospital, Tong Ji University, Shanghai
The University of Hong Kong
OTHER
Shanghai First Maternity and Infant Hospital
OTHER